Application of Zishen Yutai Pills in the preparation of medicines for preventing preeclampsia
A pre-eclampsia and kidney-nourishing technology, applied in the field of medicine, to achieve the effects of inhibiting the progress of the disease, increasing the normal weight rate, and good effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] Example 1 The effect of Zishen Yutai Pill on the condition of pregnant women with high risk of preeclampsia
[0022] (1) The purpose of the experiment
[0023] By comparison, the clinical curative effect of the present invention on the disease control of pregnant women with high risk of preeclampsia is analyzed and evaluated.
[0024] (2) Experimental methods and results
[0025] A total of 160 pregnant women who met the high-risk criteria for preeclampsia from 2016 to 2017 were selected and randomly divided into Zishen Yutai Pills group and placebo group according to the order of visits.
[0026] Source of patients: All cases were from outpatients of the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine.
[0027] Inclusion criteria:
[0028] 1. 12-20 weeks of pregnancy, singleton;
[0029] 2. At least one of the following conditions: pre-pregnancy BMI ≥ 30; diabetes; chronic hypertension; past history of placental abruption; past his...
Embodiment 2
[0044] Example 2 Effects of Zishen Yutai Pills on pregnancy outcomes of pregnant women with high risk of preeclampsia
[0045] (1) The purpose of the experiment
[0046] By comparison, the clinical curative effect of the present invention on pregnancy outcome of pregnant women with high risk of preeclampsia is analyzed and evaluated.
[0047] (2) Experimental methods and results
[0048] A total of 130 pregnant women who met the high-risk criteria for preeclampsia from 2016 to 2017 were selected and randomly divided into Zishen Yutai Pills group and placebo group according to the order of visits.
[0049] Source of patients: All cases were from outpatients of the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine.
[0050] Inclusion criteria:
[0051] 1. 12-20 weeks of pregnancy, singleton;
[0052] 2. At least one of the following conditions: pre-pregnancy BMI ≥ 30; diabetes; chronic hypertension; past history of placental abruption; past hi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com